John Klock - TechniScan Insider

TSNI -- USA Stock  

USD 0.0035  0.00  0.00%

  Executive
Dr. John C. Klock, M.D. is a Chief Medical Officer of TechniScan Inc. Dr. Klock had been the Chief Medical Officer of TechniScan Utah since June 2009. As a result of the Merger, effective as of October 9, 2009, he became the Company Chief Medical Officer. Prior to serving as the Chief Medical Officer, Dr. Klock had been a member of the Board of TechniScan Utah from February 2007 until June 2009. Dr. Klock received his medical degree from Tulane University, and completed his medical training at the University of CaliforniaSan Francisco and Massachusetts General Hospital. Dr. Klock is a boardcertified Internist and HematologistOncologist who practiced medicine and did research at the University of CaliforniaSan Francisco from 1970 to 1982. Since 1982, Dr, Klock was involved in the startup of five medical companies. Dr. Klock has authored over 70 peerreviewed medical and scientific publications and is listed as an inventor on 8 United States patents.
Age: 66  Executive Since 2009      
801-521-0444  http://www.techniscanmedicalsystems.com

Management Efficiency

The company has return on total asset (ROA) of (234.43) % which means that it has lost $234.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (5899.8) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 2.79 M in liabilities. TechniScan has Current Ratio of 0.13 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

TechniScan, Inc., a development stage company, engages in the research, development, and commercialization of non-invasive medical imaging products for the detection and diagnosis of breast cancer. It intends to develop the Warm Bath Ultrasound system, an ultrasound-based imaging device that provides radiologists with information about the bulk properties of tissue in the breast, as well as images of the tissue structure. TechniScan operates under Medical Devices classification in USA and traded on OTC Market. It employs 5 people.TechniScan (TSNI) is traded on OTC Market in USA. It is located in 3216 South Highland Drive and employs 5 people.

TechniScan Leadership Team

David Robinson, CEO and President and Director
Cheryl Cook, Director
Joseph Pepper, Director
Kenneth Hungerford, Chairman of the Board
Barry Hanover, COO and Director
John Klock, Chief Medical Officer
Richard Stanley, Director
Steven Passey, CFO, Secretary
Gerald Richardson, Director

Stock Performance Indicators

Current Sentiment - TSNI

TechniScan Investor Sentiment
Macroaxis portfolio users are evenly split in their outlook on investing in TechniScan. What is your outlook on investing in TechniScan? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip
Currently Active Assets on Macroaxis
MSFT   
Purchased over 20 shares of
2 days ago
Traded for 106.27
F   
Purchased over 200 shares of
2 days ago
Traded for 10.56
GM   
Purchased over 70 shares of
2 days ago
Traded for 39.4
GOOG   
Purchased few shares of
2 days ago
Traded for 1184.91
C   
Purchased over 40 shares of
2 days ago
Traded for 69.22
Also please take a look at World Market Map. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">